Paper40831704
TLR3 rs3775291 C/T polymorphism is associated with elevated IFN-α level in asymptomatic HTLV-1 infection.
Ferreira FDS and 12 others. Front Cell Infect Microbiol, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. TLR3 rs3775291 C/T polymorphism is associated with elevated IFN-α level in asymptomatic HTLV-1 infection. Papers, record 40831704. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40831704
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- TLR3 rs3775291 C/T polymorphism is associated with elevated IFN-α level in asymptomatic HTLV-1 infection.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Toll-Like Receptor 3 | Major topic |
| HTLV-I Infections | Major topic |
| Polymorphism, Single Nucleotide | Major topic |
| Interferon-alpha | Major topic |
| Human T-lymphotropic virus 1 | Major topic |
| Asymptomatic Infections | Major topic |
| Humans | |
| Male | |
| Female | |
| Middle Aged | |
| Adult | |
| Viral Load | |
| Genotype | |
| Genetic Predisposition to Disease | |
| Cytokines | |
| Aged |
Source PubMed
References73
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21478870 | A diverse range of gene products are effectors of the type I interferon antiviral response. | Nature | 2011 | https://conductscience.org/library/papers/21478870 | PubMed |
| 2 | 28009434 | Gene polymorphisms of TLR2 and TLR3 in HBV clearance and HBV-related hepatocellular carcinoma in a Chinese male population. | Int J Biol Markers | 2017 | https://conductscience.org/library/papers/28009434 | PubMed |
| 3 | 37242405 | Mechanisms of Innate Immune Sensing of HTLV-1 and Viral Immune Evasion. | Pathogens | 2023 | https://conductscience.org/library/papers/37242405 | PubMed |
| 4 | 35967300 | Influence of single-nucleotide polymorphisms in TLR3 (rs3775291) and TLR9 (rs352139) on the risk of CMV infection in kidney transplant recipients. | Front Immunol | 2022 | https://conductscience.org/library/papers/35967300 | PubMed |
| 5 | 10534152 | Prospective study of HTLV-I infection in an initially asymptomatic cohort. | J Acquir Immune Defic Syndr | 1999 | https://conductscience.org/library/papers/10534152 | PubMed |
| 6 | 24701034 | Hantaan virus infection induces CXCL10 expression through TLR3, RIG-I, and MDA-5 pathways correlated with the disease severity. | Mediators Inflamm | 2014 | https://conductscience.org/library/papers/24701034 | PubMed |
| 7 | 39650644 | TLR7 rs179008 (A/T) and TLR7 rs3853839 (C/G) polymorphisms are associated with variations in IFN-α levels in HTLV-1 infection. | Front Immunol | 2024 | https://conductscience.org/library/papers/39650644 | PubMed |
| 8 | 32835825 | An update on human T-cell leukemia virus type I (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) focusing on clinical and laboratory biomarkers. | Pharmacol Ther | 2021 | https://conductscience.org/library/papers/32835825 | PubMed |
| 9 | 8429097 | Detection of tumor necrosis factor-alpha-positive cells in cerebrospinal fluid of patients with HTLV-I-associated myelopathy. | J Neuroimmunol | 1993 | https://conductscience.org/library/papers/8429097 | PubMed |
| 10 | 11420036 | Interferons alpha and beta as immune regulators--a new look. | Immunity | 2001 | https://conductscience.org/library/papers/11420036 | PubMed |
| 11 | 18202435 | Sensing of viral infection and activation of innate immunity by toll-like receptor 3. | Clin Microbiol Rev | 2008 | https://conductscience.org/library/papers/18202435 | PubMed |
| 12 | 2871307 | HTLV-I associated myelopathy, a new clinical entity. | Lancet | 1986 | https://conductscience.org/library/papers/2871307 | PubMed |
| 13 | 15070424 | Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers. | BMC Infect Dis | 2004 | https://conductscience.org/library/papers/15070424 | PubMed |
| 14 | 17395581 | Toll-like receptors and Type I interferons. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17395581 | PubMed |
| 15 | 19953531 | Assessing individual interethnic admixture and population substructure using a 48-insertion-deletion (INSEL) ancestry-informative marker (AIM) panel. | Hum Mutat | 2010 | https://conductscience.org/library/papers/19953531 | PubMed |
| 16 | 35419336 | The Relevance of a Diagnostic and Counseling Service for People Living With HTLV-1/2 in a Metropolis of the Brazilian Amazon. | Front Public Health | 2022 | https://conductscience.org/library/papers/35419336 | PubMed |
| 17 | 36189294 | T cell receptor repertoire analysis in HTLV-1-associated diseases. | Front Immunol | 2022 | https://conductscience.org/library/papers/36189294 | PubMed |
| 18 | 34964709 | The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males. | Autophagy | 2022 | https://conductscience.org/library/papers/34964709 | PubMed |
| 19 | 17434873 | Effects of single nucleotide polymorphisms on Toll-like receptor 3 activity and expression in cultured cells. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17434873 | PubMed |
| 20 | 15145617 | Th1/Th2 balance and HTLV-I proviral load in HAM/TSP patients treated with interferon-alpha. | J Neuroimmunol | 2004 | https://conductscience.org/library/papers/15145617 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42238818 | The association of the TLR3 SNP rs3775291 with schizophrenia is influenced by age. | Front Genet | 2026 | https://conductscience.org/library/papers/42238818 | PubMed |
| 41920397 | Interferon dynamics in deltaretroviruses: why HTLV-1 evades, but BLV responds. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/41920397 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNA1 | 3439 | PubTator's text mining | https://conductscience.org/library/genes/3439 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| TLR3 | 7098 | PubTator's text mining | https://conductscience.org/library/genes/7098 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40831704
GET https://conductscience.org/api/papers/v1/40831704/references?page=2